27-Hydroxycholesterol upregulates the production of heat shock protein 60 of monocytic cells

J Steroid Biochem Mol Biol. 2017 Sep:172:29-35. doi: 10.1016/j.jsbmb.2017.04.015. Epub 2017 May 24.

Abstract

Investigating differentially expressed proteins in a milieu rich in cholesterol oxidation products, we found via mass spectrometry-based proteomics that surface levels of heat shock protein 60 (HSP60) were upregulated on monocytic cells in the presence of 27-hydroxycholesterol (27OHChol). The elevated levels of cytoplasmic membrane HSP60 were verified via Western blot analysis and visualized by confocal microscopy. Treatment with 27OHChol also resulted in increased levels of cellular HSP60 without altering its transcription. Cholesterol, however, did not affect cell-surface levels and cellular amount of HSP60. GSK 2033, an LXR antagonist, inhibited expression of live X receptor α, but not of HSP60, induced by 27OHChol. Treatment with 27OHChol also resulted in increased release of HSP60 from monocytic cells, but the release was significantly reduced by inhibitors of endoplasmic reticulum-Golgi protein trafficking, brefeldin A and monensin. Results of the current study indicate that 27OHChol upregulates not only cell-surface and cellular levels of HSP60 but also its release from monocytic cells, thereby contributing to activation of the immune system.

Keywords: 27-Hydroxycholesterol; Heat shock protein 60; Live X receptor (LXR) monocytes/macrophages.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Brefeldin A / pharmacology
  • Cell Line
  • Cell Membrane / drug effects
  • Cell Membrane / immunology
  • Cell Membrane / metabolism
  • Chaperonin 60 / agonists
  • Chaperonin 60 / genetics*
  • Chaperonin 60 / metabolism
  • Endoplasmic Reticulum / drug effects
  • Endoplasmic Reticulum / immunology
  • Endoplasmic Reticulum / metabolism
  • Gene Expression Regulation
  • Golgi Apparatus / drug effects
  • Golgi Apparatus / immunology
  • Golgi Apparatus / metabolism
  • Humans
  • Hydroxycholesterols / metabolism
  • Hydroxycholesterols / pharmacokinetics*
  • Immunity, Cellular
  • Liver X Receptors / antagonists & inhibitors
  • Liver X Receptors / genetics
  • Liver X Receptors / metabolism
  • Mitochondrial Proteins / agonists
  • Mitochondrial Proteins / genetics*
  • Mitochondrial Proteins / metabolism
  • Monensin / pharmacology
  • Monocytes / cytology
  • Monocytes / drug effects*
  • Monocytes / immunology
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Sulfonamides / pharmacology
  • Transcription, Genetic

Substances

  • 2,4,6-trimethyl-N-((3'-(methylsulfonyl)-4-biphenylyl)methyl)-N-((5-(trifluoromethyl)-2-furanyl)methyl)benzenesulfonamide
  • Chaperonin 60
  • HSPD1 protein, human
  • Hydroxycholesterols
  • Liver X Receptors
  • Mitochondrial Proteins
  • Sulfonamides
  • Brefeldin A
  • 27-hydroxycholesterol
  • Monensin